PMV Pharmaceuticals, Inc. - 10-Q Filing
PMV Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended March 31, 2026. The filing includes unaudited financial statements showing continued operational losses and no revenue from product sales as of this quarter.
Tickers: $PMVP